Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
glp-1 drugs and alzheimer's Agonists Dementia Peptide Synthesis Quantity:Double-Pack ($69) Retatrutide is a triple-agonist
Retatrutide is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing
REDUCE HUNGER & CRAVINGS*: Patented Supresa® saffron extract is shown to reduce hunger and snacking in as early as 8 weeks in clinical study participants.*
Peptide Synthesis
Quantity:Double-Pack ($69)
Hirsch IB, Buse JB, Leahy J, et al
US$ 26.24
US$ 29.65
US$ 21.10
US$ 27.51
US$ 29.80
US$ 26.35
US$ 28.85
